New patent for the drug Dermavant Sci VTAMA – DrugPatentWatch

Less than a minute

Annual Drug Patent Expiration for VTAMA

Vtama is a drug marketed by Dermavant Sci and is included in one NDA. It is available from a single supplier. There are four patents protecting this drug.

This drug has fifty-eight patent family members in thirty-six countries.

The generic material in VTAMA is butinaroof. One registered supplier for this compound. Additional details are available on tapinarof’s profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com